Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Table of contents
Table of contents
Email alerts
Table of contents
Prev issue
Next issue
April 2005 - Volume 15 - Suppl 1
INTRODUCTION
ARTICLES
INTRODUCTION
Introduction to the Pre–International Gynecologic Cancer Society Roundtable Meeting: successful management of ovarian cancer
(1 April, 2005)
Andreas
du Bois
,
Robert
Ozols
ARTICLES
Treatment goals in ovarian cancer
(1 April, 2005)
R. F.
Ozols
Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic
(1 April, 2005)
M. A.
Bookman
Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma
(1 April, 2005)
P. G.
Rose
Review of gemcitabine-based combinations for platinum-resistant ovarian cancer
(1 April, 2005)
J.
Sehouli
Management of platinum-sensitive relapsed ovarian cancer, with particular reference to the International Collaboration in Ovarian Neoplasm-4/Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer-2.2 trial
(1 April, 2005)
S. B.
Kaye
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer
(1 April, 2005)
J.
Pfisterer
,
I.
Vergote
,
A.
Du Bois
,
E.
Eisenhauer
Future options for first-line therapy of advanced ovarian cancer
(1 April, 2005)
A.
Du Bois
,
J.
Pfisterer